Berkley W R Corp Takes $3.20 Million Position in Translational Development Acquisition Corp. (NASDAQ:TDACU)

Berkley W R Corp purchased a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 173,530 shares of the company’s stock, valued at approximately $3,200,000.

A number of other large investors have also made changes to their positions in TDACU. Magnetar Financial LLC purchased a new position in Translational Development Acquisition in the fourth quarter worth approximately $23,972,000. Crossingbridge Advisors LLC purchased a new position in shares of Translational Development Acquisition during the fourth quarter worth $11,064,000. Calamos Advisors LLC purchased a new position in shares of Translational Development Acquisition during the fourth quarter worth $6,915,000. Shaolin Capital Management LLC purchased a new position in shares of Translational Development Acquisition during the fourth quarter worth $6,915,000. Finally, MMCAP International Inc. SPC purchased a new position in shares of Translational Development Acquisition during the fourth quarter worth $6,454,000.

Translational Development Acquisition Stock Up 0.1 %

TDACU opened at $10.20 on Tuesday. Translational Development Acquisition Corp. has a 52 week low of $10.00 and a 52 week high of $10.30. The stock’s fifty day moving average price is $10.16.

About Translational Development Acquisition

(Free Report)

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.

Featured Stories

Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report).

Institutional Ownership by Quarter for Translational Development Acquisition (NASDAQ:TDACU)

Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.